NCT00723021 - PF-04191834 Single Dose Bronchodilatory Study In Asthma. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

December 31, 2008

Study Completion Date

July 31, 2009

Conditions

Asthma

Interventions

DRUG

PF-04191834

30mg PF-04191834, single dose, oral dispersion + 2 x placebo tablets.

DRUG

PF-04191834

100mg PF-04191834, single dose, oral dispersion + 2 x placebo tablets, single dose.

DRUG

PF-04191834

2000mg PF-04191834, single dose, oral dispersion + 2 x placebo tables, single dose

DRUG

zileuton

1200mg, 2 x 600mg tablets, single dose + placebo oral dispersion, single dose.

DRUG

Placebo

2 x placebo tablets + placebo oral dispersion, single dose.

Trial Locations (4)

Pfizer Investigational Site, Baltimore

Pfizer Investigational Site, Kalamazoo

Pfizer Investigational Site, Omaha

Pfizer Investigational Site, North Dartmouth